Study to Evaluate Safety, Tolerability and Explorative Efficacy of DM-101PX in Birch Pollen Allergic Participants

NCT06037148 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Birch Pollen Allergy

Interventions

BIOLOGICAL: DM-101PX
BIOLOGICAL: Placebo to Match DM-101PX

Sponsor

Desentum Oy